Product Information
FLECAINIDE ACETATE 50 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.1084 per EA under NDC 62135066060. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Jul 9, 2009.
Strength
50 mg/1
Manufacturer
Chartwell RX LLCNDC
62135066060
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLECAINIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA079164FDA Approved
7/9/2009
On Market Since
7/9/2009
Pharmacological Classes
Price Statistics
The NADAC for FLECAINIDE ACETATE 50 MG TAB has been published 114 times since Jul 31, 2024, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1084 per EA |
|---|---|
| All-time high | $0.1172 (Sep 11, 2024) |
| All-time low | $0.0874 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1084 |
| Median price | $0.1127 |
| Average price | $0.1111 |
| Largest weekly change | -23.4% (Nov 20, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flecainide Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLECAINIDE ACETATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLECAINIDE ACETATE 50 MG TAB, manufactured by Chartwell RX LLC, is $0.1084 per EA (NDC 62135066060), effective Sep 30, 2026.
How has the price of FLECAINIDE ACETATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for FLECAINIDE ACETATE 50 MG TAB has risen 3.6%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for FLECAINIDE ACETATE 50 MG TAB?
Since Jul 31, 2024, the NADAC for FLECAINIDE ACETATE 50 MG TAB has ranged from a low of $0.0874 (Nov 20, 2024) to a high of $0.1172 (Sep 11, 2024), with a median of $0.1127 per EA.
Are there cheaper alternatives to FLECAINIDE ACETATE 50 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLECAINIDE ACETATE 50 MG TAB, is $0.0972 per EA — about 10% below FLECAINIDE ACETATE 50 MG TAB.
Who manufactures FLECAINIDE ACETATE 50 MG TAB?
FLECAINIDE ACETATE 50 MG TAB (NDC 62135066060) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.